• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Crit Care Med . Characteristics and Outcomes of Critically Ill Children With Multisystem Inflammatory Syndrome

tetano

Editor, Senior Moderator
Pediatr Crit Care Med


. 2022 Aug 22.
doi: 10.1097/PCC.0000000000003054. Online ahead of print.
Characteristics and Outcomes of Critically Ill Children With Multisystem Inflammatory Syndrome


Kellie Snooks[SUP] 1 [/SUP], Matthew C Scanlon[SUP] 1 [/SUP], Kenneth E Remy[SUP] 2 [/SUP], Steven L Shein[SUP] 2 [/SUP], Margaret J Klein[SUP] 3 [/SUP], Janine Zee-Cheng[SUP] 4 [/SUP], Colin M Rogerson[SUP] 4 [/SUP], Alexandre T Rotta[SUP] 5 [/SUP], Anna Lin[SUP] 6 [/SUP], Casey K McCluskey[SUP] 7 [/SUP], Christopher L Carroll[SUP] 8 [/SUP]



Affiliations

Abstract

Objectives: To characterize the prevalence of pediatric critical illness from multisystem inflammatory syndrome in children (MIS-C) and to assess the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain on outcomes.
Design: Retrospective cohort study.
Setting: Database evaluation using the Virtual Pediatric Systems Database.
Patients: All children with MIS-C admitted to the PICU in 115 contributing hospitals between January 1, 2020, and June 30, 2021.
Measurements and main results: Of the 145,580 children admitted to the PICU during the study period, 1,338 children (0.9%) were admitted with MIS-C with the largest numbers of children admitted in quarter 1 (Q1) of 2021 (n = 626). The original SARS-CoV-2 viral strain and the D614G Strain were the predominant strains through 2020, with Alpha B.1.1.7 predominating in Q1 and quarter 2 (Q2) of 2021. Overall, the median PICU length of stay (LOS) was 2.7 days (25-75% interquartile range [IQR], 1.6-4.7 d) with a median hospital LOS of 6.6 days (25-75% IQR, 4.7-9.3 d); 15.2% received mechanical ventilation with a median duration of mechanical ventilation of 3.1 days (25-75% IQR, 1.9-5.8 d), and there were 11 hospital deaths. During the study period, there was a significant decrease in the median PICU and hospital LOS and a decrease in the frequency of mechanical ventilation, with the most significant decrease occurring between quarter 3 and quarter 4 (Q4) of 2020. Children admitted to a PICU from the general care floor or from another ICU/step-down unit had longer PICU LOS than those admitted directly from an emergency department.
Conclusions: Overall mortality from MIS-C was low, but the disease burden was high. There was a peak in MIS-C cases during Q1 of 2021, following a shift in viral strains in Q1 of 2021. However, an improvement in MIS-C outcomes starting in Q4 of 2020 suggests that viral strain was not the driving factor for outcomes in this population.
 
Back
Top Bottom